Growth Metrics

Medifast (MED) Debt to Equity (2022)

Medifast (MED) has disclosed Debt to Equity for 6 consecutive years, with $0.21 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Debt to Equity changed N/A year-over-year to $0.21, compared with a TTM value of $0.21 through Jun 2022, changed N/A, and an annual FY2013 reading of $0.0, down 94.38% over the prior year.
  • Debt to Equity was $0.21 for Q2 2022 at Medifast, up from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.21 in Q2 2022 and bottomed at $0.21 in Q2 2022.